1. The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders
   Jacopo Di Gregorio et al, 2020, Frontiers in Cell and Developmental Biology CrossRef
2. Acetyl‐11‐keto‐β‐boswellic acid ameliorates renal interstitial fibrosis via Klotho/TGF‐β/Smad signalling pathway
   Minna Liu et al, 2018, Journal of Cellular and Molecular Medicine CrossRef
3. Baicalin protects against renal interstitial fibrosis in mice by inhibiting the TGF-β/Smad signalling pathway
   Hui Wang et al, 2022, Pharmaceutical Biology CrossRef
4. Kidney-targeted baicalin-lysozyme conjugate ameliorates renal fibrosis in rats with diabetic nephropathy induced by streptozotocin
   Xiao-peng Zheng et al, 2020, BMC Nephrology CrossRef
5. Small molecules against the origin and activation of myofibroblast for renal interstitial fibrosis therapy
   Ya-long Feng et al, 2021, Biomedicine & Pharmacotherapy CrossRef
6. Down-regulation of LINC00667 hinders renal tubular epithelial cell apoptosis and fibrosis through miR-34c
   P. Huang et al, 2021, Clinical and Translational Oncology CrossRef
7. TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis
   Xiao-Yong Yu et al, 2022, Frontiers in Pharmacology CrossRef
8. Effects of Eucommia ulmoides extract against renal injury caused by long-term high purine diets in rats
   An Li et al, 2021, Food & Function CrossRef
9. Baicalin Alleviates Silica-Induced Lung Inflammation and Fibrosis by Inhibiting TLR4/NF-κB Pathway in Rats
   Y Zhang et al, 2023, Physiological Research CrossRef
10. Flavonoids in Kidney Health and Disease
    Félix Vargas et al, 2018, Frontiers in Physiology CrossRef
11. Natural products in regeneration
    Rachel B. Wilson et al, 2022, Regenerative Nephrology CrossRef
12. Long noncoding RNA growth arrest‐specific transcript 5 alleviates renal fibrosis in diabetic nephropathy by downregulating matrix metalloproteinase 9 through recruitment of enhancer of zeste homolog 2
    Lei Zhang et al, 2020, The FASEB Journal CrossRef
13. Baicalin attenuates liver hypoxia/reoxygenation injury by inducing autophagy
    Feng Liu et al, 2018, Experimental and Therapeutic Medicine CrossRef
14. Histomorphological, VEGF and TGF-β immunoexpression changes in the diabetic rats’ ovary and the potential amelioration following treatment with metformin and insulin
    Eyad M. T. Ali et al, 2020, Journal of Molecular Histology CrossRef
15. Therapeutic and delivery strategies of phytoconstituents for renal fibrosis
    Huan Xu et al, 2021, Advanced Drug Delivery Reviews CrossRef
16. Shenkang injection protects against renal fibrosis by reducing perforin expression through the STING/TBK1/IRF3 signaling pathways in natural killer cells
    Junfeng Hao et al, 2022, Phytomedicine CrossRef
17. Saroglitazar attenuates renal fibrosis induced by unilateral ureteral obstruction via inhibiting TGF-β/Smad signaling pathway
    Mirhan N. Makled et al, 2020, Life Sciences CrossRef
18. Baicalin suppresses renal fibrosis through microRNA-124/TLR4/NF-κB axis in streptozotocin-induced diabetic nephropathy mice and high glucose-treated human proximal tubule epithelial cells
    Shefeng Zhang et al, 2020, Journal of Physiology and Biochemistry CrossRef
19. DHEA-induced ovarian hyperfibrosis is mediated by TGF-β signaling pathway
    Daojuan Wang et al, 2018, Journal of Ovarian Research CrossRef
20. Baicalin inhibits pressure overload-induced cardiac fibrosis through regulating AMPK/TGF-β/Smads signaling pathway
    Yichuan Xiao et al, 2018, Archives of Biochemistry and Biophysics CrossRef
21. Baicalin alleviates bleomycin‑induced pulmonary fibrosis and fibroblast proliferation in rats via the PI3K/AKT signaling pathway
    Hong Zhao et al, 2020, Molecular Medicine Reports CrossRef